Last updated on November 2017

A Phase 4 clinical trial for adolescents (6-16) with Anxiety, Depression, or OCD.


Brief description of study

A Phase 4 clinical trial for adolescents (6-16) with Anxiety, Depression, or OCD.

Detailed Study Description

A clinical study designed to collect information on the safety and efficacy of an anti-depressant to treat depression, OCD, or anxiety with or without CBT therapy.

Clinical Study Identifier: TX7120

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Whitney Vaughan

Harmonex Neuroscience Research of Pensacola
Pensacola, FL USA
  Connect »